La greffe *2009*mutations of mortality: Transplants - a conclusion: "So, what is the conclusion? Who should have a transplant and when. As usual, the best results are achieved in people who don't need one, and..."
*2009*mutations of mortality: Specific transplant problems in CLL: "Transplants are more likely to be rejected in CLL than in other conditions. The rejection rate in follicular lymphoma is between 3 and 6%. F..."
*2009*mutations of mortality: What are the alternatives to transplantation?: "In patients who are fludarabine refractory or have a p53 dysfunction the available treatments are limited. The first drug that comes to mind..."
*2009*mutations of mortality: Transplants: ablative or non-ablative?: "Continuing from yesterday. Should one go for an ablative or non-ablative transplant? Ablative means using sufficient chemotherapy to destroy..."
*2009*mutations of mortality: Who needs a transplant?: "I think another article about bone marrow transplants is due. A paper has appeared in Blood detailing the European experience in CLL, so it ..."
*2009*mutations of mortality: Should I have a transplant 2?: "Here is the attraction of stem cell transplants: they cure people. Here is the problem with stem cell transplants in CLL: they kill people. ..."
*2009*mutations of mortality: Should I go for a transplant?: "Should I go for a transplant or not? This is often a difficult question for patients with CLL. Until recently the answer was, “Not if you ca..."
*2008*mutations of mortality: 1000 transplants: "I spent yesterday at the celebration in London of the Kings College Hospital's one thousandth stem cell transplant. Although not rivalling S..."
*2008*mutations of mortality: stem cell transplants - a personal history: "I was first involved in a bone marrow transplant (BMT) in 1970. We attempted to transplant bone marrow into a toddler with aplastic anemia f..."
*2008*mutations of mortality: Transplants in CLL: "I thought you might be interested in this provisional guideline for when to do a transplant in CLL. 1. Very high risk CLL defined as CLL wi..."
*2007*mutations of mortality: Stem cell transplant - a lifelong committment: "Some people think I am against transplants. Not at all, I regularly attend a ward round at the biggest transplant center in Britain. Ther..."
*2007*mutations of mortality: Bone marrow transplantation for CLL: "This is the next section in the article that I am writing in the Lancet. In leukemia, remissions are traditionally consolidated with high d..."
Libellés
LLC
(100)
LLC 11q-
(2)
LLC anticorp monoclonal
(4)
LLC avis sur les traitements
(2)
LLC consultation mon cas
(11)
LLC Définition
(2)
LLC Dr Terry Hamblin
(13)
LLC éléments analysés
(5)
LLC Essais Cliniques
(11)
LLC étude d'un point
(4)
LLC exemple de traitement
(1)
LLC Genetique
(2)
LLC groupe de patients
(1)
LLC immunodepression
(1)
LLC les bases
(1)
LLC Mes Analyses
(6)
LLC molecule
(16)
LLC Molecule Arzerra
(1)
LLC Molecule Cirmtuzumab
(1)
LLC Molecule Gaziva
(1)
LLC molecule Ibrutinib
(3)
LLC molecule idelalisib
(2)
LLC MonTraitement1
(9)
LLC revue du net
(1)
LLC statistique survie
(8)
LLC témoignage après chimio
(1)
LLC témoignage chimio
(4)
LLC TH But du traitement
(1)
LLC TH Conseils
(1)
LLC TH CT scan
(1)
LLC TH Etudes
(1)
LLC TH Greffe
(1)
LLC TH Immunodeficience
(2)
LLC TH Les Traitements
(1)
LLC TH MBR
(1)
LLC TH Molecules
(1)
LLC TH Pronostiqueurs
(1)
LLC Traitement
(10)
LLC video
(1)
Traitement
(1)
Inscription à :
Publier les commentaires (Atom)
Aucun commentaire:
Enregistrer un commentaire